The University of Alabama at Birmingham Marnix E. Heersink School of Medicine is a public medical school located in Birmingham, Alabama, United States with branch campuses in Huntsville, Montgomery, and at the University of Alabama College of Community Health Sciences in Tuscaloosa.

During the past decade, University of Alabama at Birmingham School of Medicine conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alabama at Birmingham School of Medicine" #1 sponsor was "Corcept Therapeutics" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Agenus Inc." with 1 trials sponsored, "Arcion Therapeutics Inc" with 1 trials sponsored and "Bayhill Therapeutics" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama at Birmingham School of Medicine" #1 collaborator was "Baylor Health Care System" with 1 trials as a collaborator, "Crowley Carter Foundation" with 1 trials as a collaborator, "Dallas Diabetes and Endocrine Center" with 1 trials as a collaborator, "Don and Linda Carter Foundation" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama at Birmingham School of Medicine" are "Cushing's Syndrome" (2 trials), "B-cell Non-Hodgkin Lymphoma" (1 trials), "COVID-19" (1 trials), "Cardiovascular Disease" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "University of Alabama at Birmingham School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Alabama at Birmingham School of Medicine" are "Drug" (18 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tocilizumab" (2 trials), "mifepristone" (2 trials), "AGEN1884" (1 trials) and "AGEN2034" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama at Birmingham School of Medicine" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Alabama at Birmingham School of Medicine". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Alabama at Birmingham School of Medicine, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama at Birmingham School of Medicine, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".